Not applicableStudy completedNCT01870479What this trial is testingMusic & Cancer - Live Music During ChemotherapyWho this might be right forNon Hodgkin´s LymphomasHodgkin´s Lymphomas Margrethe Langer Bro 143
Not applicableUnknownNCT04090268What this trial is testingPrecision Exercise in Children With Malignant HemopathiesWho this might be right forLeukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T Cell+5 more University of Milano Bicocca 380
Testing effectiveness (Phase 2)Looking for participantsNCT06151080What this trial is testingLenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FLWho this might be right forDLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma The First Affiliated Hospital of Xiamen University 38
Testing effectiveness (Phase 2)UnknownNCT02942043What this trial is testingBevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung CancerWho this might be right forMalignant Pleural Effusion Peking University Cancer Hospital & Institute 87
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Not applicableStudy completedNCT04464590What this trial is testingInterest of a Systematic One-year Monitoring by 18F-FDG PET-CTWho this might be right forMalignant LymphomaRelapsed Non Hodgkin LymphomaRelapsed Hodgkin's Disease, Adult+1 more University Hospital, Brest 100
Testing effectiveness (Phase 2)Study completedNCT00003874What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714What this trial is testingErdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02991898What this trial is testingAdoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00564733What this trial is testingFDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer University of Washington 55
Testing effectiveness (Phase 2)Study completedNCT04191187What this trial is testingReduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBiphenotypic Acute Leukemia+15 more H. Lee Moffitt Cancer Center and Research Institute 34
Large-scale testing (Phase 3)Looking for participantsNCT05727904What this trial is testingStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.Who this might be right forMetastatic MelanomaUnresectable MelanomaMelanoma Iovance Biotherapeutics, Inc. 670
Not applicableEnded earlyNCT00524485What this trial is testingPhotodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic KeratosisWho this might be right forPrecancerous/Nonmalignant Condition Roswell Park Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Early research (Phase 1)Study completedNCT01137006What this trial is testingAn Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant MelanomaWho this might be right forMalignant Melanoma Eli Lilly and Company 27
Early research (Phase 1)Ended earlyNCT06270082What this trial is testingStudy of IK-595 in RAS- or RAF-altered Advanced TumorsWho this might be right forSolid Tumor, AdultColorectal CancerPancreatic Cancer+7 more Ikena Oncology 75
Not applicableStudy completedNCT00974610What this trial is testingStudy of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.Who this might be right forBreast CancerColorectal CancerLung Cancer+2 more Cancer Trials Ireland 803
Not applicableWithdrawnNCT05169151What this trial is testingMobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA StudyWho this might be right forCentral Nervous System NeoplasmHodgkin LymphomaMalignant Solid Neoplasm+2 more M.D. Anderson Cancer Center
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221